COMPANY

Gradient Medical, Inc.

Keywords: oncology cancer

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.15M (STTR Phase II 5R42CA275587-03, continuation, notice Sep 17, 2026). NIH RePORTER 5R42CA275587-03 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 5R42CA275587-03
  Organization: GRADIENT MEDICAL, INC.; City/State: Raleigh, NC; Project number: 5R42CA275587-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1150000; Administering IC: National Cancer Institute; Project title: Commercialization of Algorithmic Non-thermal Ablation Technology for the Treatment of Inoperable Tumors; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 17, 2026 Grant Government grant — STTR: $1.15M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Sep 8, 2025 Grant Government grant — STTR: $1.15M (annual award, as published), announced Sep 8, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Sep 17, 2026 Government grant — STTR: $1.15M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Sep 8, 2025 Government grant — STTR: $1.15M (annual award, as published), announced Sep 8, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Annual award amounts. Total $511K.

Sep 16, 2022 NIH award 1R41CA275587-01 FY2022: $259,549 awarded for that fiscal year; activity R41 (STTR); PI FONG, JORDAN; recipient as written: GRADIENT MEDICAL, INC., Raleigh, NC. Feasibility of a Multi-Phase Algorithmic Non-T source ↗
Aug 26, 2021 NIH award 1R43GM143999-01 FY2021: $251,914 awarded for that fiscal year; activity R43 (SBIR); PI FONG, JORDAN; recipient as written: GRADIENT MEDICAL, INC., Raleigh, NC. Feasibility of INSPIRE Technology to Enhance C source ↗